Yestar Healthcare to Review H1 2026 Results and Consider Interim Dividend on 28 August 2026

Bulletin Express

08/17

Yestar Healthcare Holdings Company Limited has scheduled a board meeting for 28 August 2026. Directors will review and approve the unaudited consolidated interim results for the six months ended 30 June 2026 and discuss the possible declaration of an interim dividend.

The notice, dated 17 August 2026, was signed by CEO and executive director Wang Chunlai on behalf of the Board. Current board composition includes executive directors Wang Chunlai, Qiao Jinrong and Liao Changxiang; non-executive director Hartono James; and independent non-executive directors Zeng Jinsong, Zhao Ziwei and Koeswondo Michael David.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1149917641"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1149917641\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1149917641?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-17 16:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149917641","market":"hk","top_or_hot":-1,"title":"Yestar Healthcare to Review H1 2026 Results and Consider Interim Dividend on 28 August 2026","media":"Bulletin Express","content":"<p>Yestar Healthcare Holdings Company Limited has scheduled a board meeting for 28 August 2026. Directors will review and approve the unaudited consolidated interim results for the six months ended 30 June 2026 and discuss the possible declaration of an interim dividend.</p>\n<p>The notice, dated 17 August 2026, was signed by CEO and executive director Wang Chunlai on behalf of the Board. Current board composition includes executive directors Wang Chunlai, Qiao Jinrong and Liao Changxiang; non-executive director Hartono James; and independent non-executive directors Zeng Jinsong, Zhao Ziwei and Koeswondo Michael David.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yestar Healthcare to Review H1 2026 Results and Consider Interim Dividend on 28 August 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYestar Healthcare to Review H1 2026 Results and Consider Interim Dividend on 28 August 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-17 16:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Yestar Healthcare Holdings Company Limited has scheduled a board meeting for 28 August 2026. Directors will review and approve the unaudited consolidated interim results for the six months ended 30 June 2026 and discuss the possible declaration of an interim dividend.</p>\n<p>The notice, dated 17 August 2026, was signed by CEO and executive director Wang Chunlai on behalf of the Board. Current board composition includes executive directors Wang Chunlai, Qiao Jinrong and Liao Changxiang; non-executive director Hartono James; and independent non-executive directors Zeng Jinsong, Zhao Ziwei and Koeswondo Michael David.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02393","symbol_name":"巨星医疗控股","start_time":0,"source_url":"","article_id":"1149917641","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149917641","pubTimestamp":1786956311,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Yestar Healthcare Holdings Company Limited has scheduled a board meeting for 28 August 2026. Directors will review and approve the unaudited consolidated interim results for the six months ended 30...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02393":"巨星医疗控股"},"translate_title":"Yestar Healthcare 将于 2026 年 8 月 28 日审查 H1 2026 业绩并考虑中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02393":1},"content_text":"Yestar Healthcare Holdings Company Limited has scheduled a board meeting for 28 August 2026. Directors will review and approve the unaudited consolidated interim results for the six months ended 30 June 2026 and discuss the possible declaration of an interim dividend.\nThe notice, dated 17 August 2026, was signed by CEO and executive director Wang Chunlai on behalf of the Board. Current board composition includes executive directors Wang Chunlai, Qiao Jinrong and Liao Changxiang; non-executive director Hartono James; and independent non-executive directors Zeng Jinsong, Zhao Ziwei and Koeswondo Michael David.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}